Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q2 2023 Earnings Call Transcript August 2, 2023
Cerevel Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $0.65.
Operator: Good morning and welcome to Cerevel Therapeutics Second Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this...
